Author:
Zhang Zhihua,Yang Xiaolu,Jin Huiyi,Qu Yuan,Zhang Yuan,Liu Kun,Xu Xun
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Horsley, M. B., Mandava, N., Maycotte, M. A. & Kahook, M. Y. Retinal nerve fiber layer thickness in patients receiving chronic anti-vascular endothelial growth factor therapy. Am J Ophthalmol. 150, 558–561.e1 (2010).
2. Wells, J. A. et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trial. Ophthalmology. 123, 1351–1359 (2016).
3. Shin, H. J., Kim, S. N., Chung, H., Kim, T. E. & Kim, H. C. Intravitreal anti-vascular endothelial growth factor therapy and retinal nerve fiber layer loss in eyes with age-related macular degeneration: a meta-analysis. Invest Ophthalmol Vis Sci. 57, 1798–1806 (2016).
4. Sobacı, G., Güngör, R. & Ozge, G. Effects of multiple intravitreal anti-VEGF injections on retinal nerve fiber layer and intraocular pressure: a comparative clinical study. Int J Ophthalmol. 6, 211–215 (2013).
5. Shin, H. J., Shin, K. C., Chung, H. & Kim, H. C. Change of retinal nerve fiber layer thickness in various retinal diseases treated with multiple intravitreal antivascular endothelial growth factor. Invest Ophthalmol Vis Sci. 55, 2403–2411 (2014).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献